Japan Artificial Kidney Market Insight
Published: 06 June 2026 | Report Format: Electronic (PDF)
The Japan artificial kidney market is projected to grow at a CAGR of 8.6%driven by a rapidly aging population, rising prevalence of CKD and ESRD, increasing adoption of portable dialysis solutions, and strong government support for renal healthcare infrastructure
Japan Artificial Kidney Market Insights Forecasts to 2035
- The Japan Artificial Kidney Market Size Was Estimated USD 1.53 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 8.6% from 2025 to 2035
- The Japan Artificial Kidney Market Size is Expected to rise around USD 3.48 Billion by 2035
Notable Insights for the Japan Artificial Kidney Market
- The product-based segmentation indicates that the Wearable Artificial Kidney & Portable Hemodialysis Systems segment holds a commanding position with almost 54% market share in the Japan Artificial Kidney Market in 2025 due to its growing usage in home-based renal care, chronic kidney disease management, and long-term dialysis therapy for elderly patients.
- The application-based segmentation shows that the Hemodialysis, Dialysis Centers & Home Care segment dominates with a market share of almost 65% in the Japan Artificial Kidney Market in 2025 as a result of widespread hospital adoption, robust reimbursement frameworks, and accelerating demand for home dialysis solutions among Japan’s aging population.
- The global revenue for Fresenius Medical Care AG in fiscal year 2025 was estimated at about EUR 21.1 billion, driven by rising demand for dialysis products and services, advanced kidney care systems, and high-volume hemodiafiltration technologies deployed across global renal care networks.
Download the eBook (ToC)
- As per expectations, increasing modernization of dialysis centers, growing AI and IoT integration in renal care devices, and rising demand for home-based treatment solutions will drive market expansion, where artificial kidney technologies improve treatment efficiency by up to 38% and reduce hospitalization dependency by up to 31%.
Research Methodologies Used to Analyze the Japan Artificial Kidney Market
The Japan artificial kidney market is analyzed through a combination of primary and secondary research approaches to ensure accurate and comprehensive market intelligence and forecasted performance. Primary research is conducted through discussions with medical device manufacturers, dialysis center operators, nephrologists, hospital procurement teams, and healthcare policy experts to analyze demand trends, technology advancements, and competitive activities. Secondary research involves analyzing company and government-published reports, medical journals and clinical research papers, import-export data, regulatory filings from PMDA, and industry association publications connected with renal care and medical devices. Market estimation, trend analysis, and forecasting methodologies are applied to estimate market size, growth opportunities, pricing dynamics, and investment patterns across the Japan artificial kidney landscape.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Artificial Kidney Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Artificial Kidney Market
- Nikkiso Co., Ltd.
- Fresenius Medical Care Japan
- Asahi Kasei Medical Co., Ltd.
- Toray Medical Co., Ltd.
- Nipro Corporation
- Terumo Corporation
- JMS Co., Ltd.
- SB-Kawasumi Laboratories, Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
Recent Developments:
- In February 2025, JMS Co., Ltd. launched its newly developed Multifunctional Single Patient Dialysis Machine “SD-X01”, featuring enhanced treatment efficiency and optimized blood purification performance, specifically designed to meet the evolving clinical requirements of Japan’s dialysis centers and home renal care settings.
- In May 2025, Asahi Kasei Medical Co., Ltd. strengthened its renal care product portfolio by launching next-generation hollow-fiber dialyzers with improved biocompatibility and superior solute clearance capabilities, aimed at elevating treatment outcomes for chronic kidney disease patients across Japan’s hospital and dialysis center network.
Market Segmentation:
Japan Artificial Kidney Market, By Product Type
- Wearable Artificial Kidney Devices
- Implantable Bioartificial Kidney Systems
- Portable Hemodialysis Machines
- Peritoneal Dialysis Systems
- Extracorporeal Blood Purification Units
Japan Artificial Kidney Market, By Technology
- AI-Enabled Renal Monitoring Systems
- IoT-Integrated Dialysis Platforms
- Automated Fluid Management Technologies
- Cloud-Based Patient Monitoring Solutions
- Bioartificial Membrane & Filtration Technologies
Japan Artificial Kidney Market, By Application
- Hemodialysis & Dialysis Centers
- Home-Based Peritoneal Dialysis
- Hospital Inpatient Renal Care
- Chronic Kidney Disease (CKD) Management
- End-Stage Renal Disease (ESRD) Treatment
Expert Views:
The growth of the artificial kidney market in Japan will be driven by the rapid rise in the incidence of chronic kidney disease and end-stage renal disease, Japan’s aging demographic profile, and the increasing adoption of advanced wearable and portable dialysis technologies that improve patient independence. The integration of AI-based renal monitoring solutions, IoT-enabled dialysis platforms, and next-generation bioartificial membrane technologies will enhance treatment outcomes, reduce hospital dependency, and strengthen demand for artificial kidney solutions across dialysis centers, hospital renal units, and home care settings throughout Japan.
Author: Aditi and Govind By Spherical Insights and Consulting